Neonc Technologies Holdings Share Price

NASDAQ: NTHI

Small Cap

$10.71

+0.57

(+5.67%)

as on September 18, 2025 at 1:29 am IST

$₹

Neonc Technologies Holdings Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$9.95
Day's Price Range
$10.85
$10.71
7.10%
Downside
1.31%
Upside
52 Week's Low
52 Week's High
$3.2
52-Week Price Range
$25
$10.71
70.12%
Downside
133.43%
Upside

Neonc Technologies Holdings share price movements today

Previous Close: $10.14
Open: $9.95
Volume: 294.1K
Day's Low - High: $9.95 - $10.85
52 Week Low - High: $3.2 - $25

Neonc Technologies Holdings Historical Returns

1 Month Return: + 94.73 %
3 Month Return: + 88.11 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Neonc Technologies Holdings Stock Fundamentals & Key Indicators

Check Neonc Technologies Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$90.8M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

441486200.00%

Neonc Technologies Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neonc Technologies Holdings with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neonc Technologies Holdings	NA	$90.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Neonc Technologies Holdings Stock's Interest Amongst Investors

Search interest for Neonc Technologies Holdings Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-44% versus previous 30 day period

Neonc Technologies Holdings Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	-	-	0	0	-	0	0	-
Gross Profit	-1	-1	0	-	0	0	-	0	0	-
Operating Income	-2	-2	-2	-4	-1	-1	-2	-2	-37	-5
EBITDA	-	-	-2	-4	-1	-3	-2	-2	-37	-5
Interest Expense	-	-	0	1	1	1	-	0	0	0
Depreciation	-	-	-	-	-	-	0	0	-	-
Income Before Tax	-2	-2	-3	-6	-2	-4	-2	-2	-38	-5
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-2	-3	-6	-2	-4	-2	-2	-38	-5
Net Profit Margin	-7339.43%	-7339.43%	0.00%	0.00%	-6834.83%	-22610.03%	0.00%	-11264.91%	-95028.72%	0.00%

Neonc Technologies Holdings Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	0	0
Gross Profit	-	0	0	0
Operating Income	-3	-2	-12	-7
EBITDA	-3	-2	-12	-9
Interest Expense	0	0	2	2
Depreciation	-	-	-	0
Income Before Tax	-3	-3	-14	-11
Income Tax Expense	-	-	-	-
Net Income	-3	-3	-14	-11
Net Profit Margin	0.00%	-15233.79%	-21176.05%	-14335.50%

Neonc Technologies Holdings Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-3	-6	-2	-4	-2	-2	-38	0
Operating Cash Flow	0	0	0	0	0	-3	0	-5	-5
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	1	2	0	11	-
Change in Cash	-	0	0	0	1	0	-1	5	-5

Neonc Technologies Holdings Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-14	-11
Operating Cash Flow	0	-1	-4
Investing Cash Flow	-	-	-
Financing Cash Flow	1	1	4
Change in Cash	0	0	0

Insights on Neonc Technologies Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, NTHI stock has moved up by 88.8%

About Neonc Technologies Holdings

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. It is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. It is developing novel drug delivery methods to be used in combination with novel drug candidates. The Company has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

Organisation	Neonc Technologies Holdings
Headquarters	23975 Park Sorrento, Calabasas, CA, United States, 91302
CEO	Dr. Thomas C. Chen M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Neonc Technologies Holdings

Name	Title
Dr. Josh Neman-Ebrahim Ph.D.	Chief Clinical Officer
Dr. Thomas C. Chen M.D., Ph.D.	Founder, CEO, Chief Scientific Officer & Director
Mr. Keithly A. Garnett	CFO & Director
Mr. Amir Farrokh Heshmatpour	President, Executive Chairman & Secretary

FAQs

What is Neonc Technologies Holdings share price today?

Neonc Technologies Holdings share price today is $10.71 as on September 18, 2025 at 1:29 am IST at the close of the market. Neonc Technologies Holdings share today touched a day high of $10.85 and a low of $9.95.

What is the 52 week high and 52 week low for Neonc Technologies Holdings share?

Neonc Technologies Holdings share touched a 52 week high of $25 on March 26, 2025 and a 52 week low of $3.2 on July 2, 2025. Neonc Technologies Holdings stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $10.71,which is 57.16% down from its 52 week high and 234.69% up from its 52 week low.

What is Neonc Technologies Holdings's market capitalisation today?

Neonc Technologies Holdings market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Neonc Technologies Holdings Stock (NTHI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neonc Technologies Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neonc Technologies Holdings Shares that will get you 0.1401 shares as per Neonc Technologies Holdings share price of $10.71 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Neonc Technologies Holdings Stock (NTHI) from India?

Indian investors can start investing in Neonc Technologies Holdings (NTHI) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 6:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Neonc Technologies Holdings stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 6:41 am IST). Based on Neonc Technologies Holdings share’s latest price of $10.71 as on September 18, 2025 at 1:29 am IST, you will get 0.9337 shares of Neonc Technologies Holdings. Learn more about fractional shares .